Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Personalized Cancer Vaccines: Clinical Landscape, Challenges, and Opportunities
Colby S. Shemesh, Joy Hsu, Iraj Hosseini, et al.
Molecular Therapy (2020) Vol. 29, Iss. 2, pp. 555-570
Open Access | Times Cited: 203

Showing 1-25 of 203 citing articles:

Neoantigen: A New Breakthrough in Tumor Immunotherapy
Zheying Zhang, Manman Lu, Yu Qin, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 220
Roles of tumor-associated macrophages in anti-PD-1/PD-L1 immunotherapy for solid cancers
Hao Zhang, Lin Liu, Jinbo Liu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 166
Vaccine delivery systems toward lymph nodes
Yingyue Ding, Zhaoting Li, Ana Jaklenec, et al.
Advanced Drug Delivery Reviews (2021) Vol. 179, pp. 113914-113914
Open Access | Times Cited: 121
Designing Cancer Immunotherapies That Engage T Cells and NK Cells
Oleksandr Kyrysyuk, Kai W. Wucherpfennig
Annual Review of Immunology (2022) Vol. 41, Iss. 1, pp. 17-38
Open Access | Times Cited: 107
Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment
Hailong Tian, Jiangjun Cao, Bowen Li, et al.
Bone Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 103
Hot and cold tumors: Immunological features and the therapeutic strategies
Lianjie Wang, Hui Geng, Yujie Liu, et al.
MedComm (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 97
The use of RNA-based treatments in the field of cancer immunotherapy
Mohammad Chehelgerdi, Matin Chehelgerdi
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 82
mRNA vaccine in cancer therapy: Current advance and future outlook
Youhuai Li, Mina Wang, Xueqiang Peng, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 8
Open Access | Times Cited: 67
Immunotherapy for Triple-Negative Breast Cancer: Combination Strategies to Improve Outcome
Liying Li, Fan Zhang, Zhenyu Liu, et al.
Cancers (2023) Vol. 15, Iss. 1, pp. 321-321
Open Access | Times Cited: 63
Recent advances in mRNA cancer vaccines: meeting challenges and embracing opportunities
Bolin Wang, Jinli Pei, Shengnan Xu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 61
The landscape of T cell antigens for cancer immunotherapy
Aviyah Peri, Nadja Salomon, Yochai Wolf, et al.
Nature Cancer (2023) Vol. 4, Iss. 7, pp. 937-954
Closed Access | Times Cited: 60
A Cancer Nanovaccine for Co-Delivery of Peptide Neoantigens and Optimized Combinations of STING and TLR4 Agonists
Jessalyn J. Baljon, Alexander J. Kwiatkowski, Hayden M. Pagendarm, et al.
ACS Nano (2024) Vol. 18, Iss. 9, pp. 6845-6862
Open Access | Times Cited: 38
Regulatory insights into nanomedicine and gene vaccine innovation: Safety assessment, challenges, and regulatory perspectives
Eliana B. Souto, Cristina Blanco-Llamero, Karolline Krambeck, et al.
Acta Biomaterialia (2024) Vol. 180, pp. 1-17
Open Access | Times Cited: 33
Cancer Nanovaccines: Nanomaterials and Clinical Perspectives
Nimeet Desai, Vivek P. Chavda, Thakur Raghu Raj Singh, et al.
Small (2024) Vol. 20, Iss. 35
Open Access | Times Cited: 24
Novel therapeutic agents in clinical trials: emerging approaches in cancer therapy
Deepak Chandra Joshi, Anurag Sharma, Sonima Prasad, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 23
Revolutionizing Cancer Treatment: Unleashing the Power of Viral Vaccines, Monoclonal Antibodies, and Proteolysis-Targeting Chimeras in the New Era of Immunotherapy
Popat Mohite, Vaishnavi Yadav, Ramdas Pandhare, et al.
ACS Omega (2024)
Open Access | Times Cited: 18
Novel lipid combination for delivery of plasmid DNA to immune cells in the spleen
Seigo Kimura, Ikramy A. Khalil, Yaser Hosny Ali Elewa, et al.
Journal of Controlled Release (2021) Vol. 330, pp. 753-764
Closed Access | Times Cited: 59
Hybrid membrane-coated nanosuspensions for multi-modal anti-glioma therapy via drug and antigen delivery
Wenyan Hao, Yuexin Cui, Yueyue Fan, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 59
Implementation of Whole-Genome and Transcriptome Sequencing Into Clinical Cancer Care
Edwin Cuppen, Olivier Elemento, Richard Rosenquist, et al.
JCO Precision Oncology (2022), Iss. 6
Open Access | Times Cited: 54
The current clinical landscape of personalized cancer vaccines
Hajer Fritah, Raphaël Rovelli, Cheryl Lai-Lai Chiang, et al.
Cancer Treatment Reviews (2022) Vol. 106, pp. 102383-102383
Open Access | Times Cited: 50
Dose–response correlation for CAR-T cells: a systematic review of clinical studies
Anand Rotte, Matthew J. Frigault, Ayub Ansari, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 12, pp. e005678-e005678
Open Access | Times Cited: 47
Development of therapeutic vaccines for the treatment of diseases
Yaomei Tian, Die Hu, Yuhua Li, et al.
Molecular Biomedicine (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 46
Novel Immunotherapies for Osteosarcoma
Yubao Lu, Jiahe Zhang, Yutong Chen, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 45
The future of cancer immunotherapy: DNA vaccines leading the way
Aanshi J. Pandya, Yesha Shah, Nirjari Kothari, et al.
Medical Oncology (2023) Vol. 40, Iss. 7
Open Access | Times Cited: 41
Advances of mRNA vaccine in tumor: a maze of opportunities and challenges
Yuan Yuan, Fan Gao, Ying Chang, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 37
Page 1 - Next Page

Scroll to top